DRLYX | MGLIX | DRLYX / MGLIX | |
Total Expense Ratio | 1.05 | 0.94 | 112% |
Annual Report Gross Expense Ratio | 1.08 | 0.95 | 114% |
Fund Existence | 12 years | 16 years | - |
Gain YTD | 6.832 | 3.616 | 189% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304M | 2.22B | 14% |
Annual Yield % from dividends | 2.61 | 2.51 | 104% |
Returns for 1 year | 10.19 | 2.42 | 422% |
Returns for 3 years | 4.62 | -3.43 | -135% |
Returns for 5 years | 25.57 | 15.01 | 170% |
Returns for 10 years | 17.30 | 32.21 | 54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMVX | 18.42 | 0.15 | +0.82% |
Voya Mid Cap Research Enhanced Index R | |||
OPTFX | 90.47 | 0.55 | +0.61% |
Invesco Discovery Large Cap A | |||
MUIGX | 17.56 | 0.07 | +0.40% |
Nationwide BNY Mellon Dyn US Core R6 | |||
GCVRX | 24.29 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R | |||
LHCTX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care R5 |